Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.41 |
| ▸ | MAOB | P27338 | 3/20 | 0.41 |
| ▸ | GSTP1 | P09211 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.39 |
| ▸ | BTK | Q06187 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12128566 | 0.93 | GSTP1 (0.46) | MAOAMAOBGSTP1GAARCE1 | |
| SCHEMBL3689582 | 0.85 | GSTP1 (0.46) | MAOAGSTP1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL12253351 | 0.84 | GSTP1 (0.44) | MAOAMAOBGSTP1BTKCYP1A2 | |
| SCHEMBL4614344 | 0.82 | GSTP1 (0.47) | MAOAGSTP1BTKCYP1A2CYP2C9 | |
| SCHEMBL3792915 | 0.82 | GSTP1 (0.55) | MAOAGSTP1CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL3687907 | 0.82 | GSTP1 (0.55) | MAOAGSTP1CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL12088900 | 0.80 | GSTP1 (0.47) | MAOAMAOBGSTP1CYP2C9CYP2C19 | |
| SCHEMBL3916691 | 0.80 | GSTP1 (0.60) | MAOAMAOBGSTP1MEN1KMT2A | |
| SCHEMBL5811792 | 0.80 | GSTP1 (0.57) | GSTP1CYP1A2CYP2C9CYP2C19CYP3A4 | |
| SCHEMBL2789566 | 0.78 | GSTP1 (0.52) | MAOAGSTP1CYP1A2CYP3A4ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9120748-B2 | Fluoranthene compound, organic electroluminescence device using the same, and solution containing organic electroluminescence material | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-01 | — | — | US | disclosed |
| US-9120748-B2 | Fluoranthene compound, organic electroluminescence device using the same, and solution containing organic electroluminescence material | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-01 | — | — | US | disclosed |
| US-20090015144-A1 | FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND SOLUTION CONTAINING ORGANIC ELECTROLUMINESCENCE MATERIAL | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-15 | — | — | US | disclosed |
| US-20090015144-A1 | FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND SOLUTION CONTAINING ORGANIC ELECTROLUMINESCENCE MATERIAL | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090015144-A1 | FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND SOLUTION CONTAINING ORGANIC ELECTROLUMINESCENCE MATERIAL | LEF1, ESD, AFF2 | MAOA 122/4885MAOB 300/4885GSTP1 2210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.